ID   LIXC002
AC   CVCL_V627
SY   LIXC-002
DR   CCRID; 4201PAT-CCTCC00382
DR   Wikidata; Q54902646
RX   Patent=CN102465113B;
RX   PubMed=24416385;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201072.
CC   Population: Chinese.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 44.71 +- 0.38 hours (PubMed=24416385).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24416385
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,14
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 15
//
RX   Patent=CN102465113B;
RA   Fan J., Qin X.-R., Zhou J., Hu G., Dai Z., Wen D.-Y., Zhang Y.-H.;
RT   "Human hepatoma carcinoma cell line and application thereof.";
RL   Patent number CN102465113B, 08-Apr-2015.
//
RX   PubMed=24416385; DOI=10.1371/journal.pone.0085308;
RA   Xin H., Wang K., Hu G., Xie F.-B., Ouyang K.-D., Tang X.-Z.,
RA   Wang M.-J., Wen D.-Y., Zhu Y.-Z., Qin X.-R.;
RT   "Establishment and characterization of 7 novel hepatocellular
RT   carcinoma cell lines from patient-derived tumor xenografts.";
RL   PLoS ONE 9:E85308-E85308(2014).
//